News
Merck & Co., Inc. (NYSE:MRK) is one of the top low volatility healthcare stocks to buy now. Analyst Daina Graybosch of ...
Analysts estimate that Merck & Co will report an earnings per share (EPS) of $2.01. Investors in Merck & Co are eagerly ...
Merck & Co., Inc. (NYSE:MRK) will release earnings results for the second quarter before the opening bell on Tuesday, July 29 ...
HHS Secretary Robert F. Kennedy Jr. said he's going to "fix" the nation's Vaccine Injury Compensation Program (VICP).
Merck is heading into its second-quarter earnings report on Tuesday with important pillars of its business increasingly under ...
52m
Barchart on MSNS&P 500 and Nasdaq 100 Post Record Highs on Trade DealsMonday closed up +0.02%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.14%, and the Nasdaq 100 Index ($IUXX) ...
Explore more
Merck Foundation Together with African and Asian First Ladies Mark 'World Assisted Reproductive Technology Day' 2025 ...
Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, SE / ACCESS Newswire / July 28, 2025 / BioInvent International AB ("BioInven ...
The biopharmaceutical process analytical technology market is projected to grow at a CAGR of ~16% over the forecast ...
Coming up: a key tariffs deadline, the Fed’s interest-rate decision, the July jobs report, fresh inflation data, and earnings ...
The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...
Merck has had a successful track record of beating estimates, having surpassed EPS expectations 88% of the time and beating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results